health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Regulation of axonal mitochondrial transport and its impact on synaptic transmission
Let me start with something that I think about constantly, both as a clinician and as someone who has personally white-knuckled her way through more extreme diets than I care to admit: losing weight is not the same thing as getting healthier
An ongoing study, however, will assess the potential of the once daily formulation
With GLP-1 therapy combined with nutritional coaching, average weight loss is typically 12 pounds per week, though individual results vary based on starting weight, adherence, medication response, and lifestyle factors